Vaxxinity Inc expected to post a loss of 10 cents a share - Earnings Preview

Vaxxinity

22/03/2024 11:17

* Vaxxinity Inc  VAXX.OQ   VAXX.O  is expected to show no
change
in quarterly revenue when it reports  results on March 25
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Vaxxinity Inc is for a
loss
of 10 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxxinity
Inc is
$11.00​, above​ its last closing price of $0.71. ​​​

This summary was machine generated March 22 at 11:17 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)